Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: A 2-year follow-up by noninvasive MRI

European Journal of Preventive Cardiology

Volumn 16, Issue 2, 2009, Pages 222-228

  Yonemura, Atsushi ^a   Momiyama, Yukihiko ^c   Fayad, Zahi A ^d   Ayaori, Makoto ^a   Ohmori, Reiko ^a   Kihara, Teruyoshi ^b   Tanaka, Nobukiyo ^a   Nakaya, Kazuhiro ^a   Ogura, Masatsune ^a   Taniguchi, Hiroaki ^a   Kusuhara, Masatoshi ^a   Nagata, Masayoshi ^b   Nakamura, Haruo ^a   Tamai, Seiichi ^a   Ohsuzu, Fumitaka ^a  

^a National Defense Medical College   (United States)

^b Iruma Heart Hospital   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

aorta; atherosclerotic plaque; lipid lowering; MRI

Indexed keywords

ATORVASTATIN; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PYRROLE DERIVATIVE; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL AORTA; AGED; AORTA DISEASE; AORTOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THORACIC AORTA; TIME; TREATMENT OUTCOME; ADULT; AORTA ATHEROSCLEROSIS; ARTERY WALL; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE COURSE; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; FOLLOW UP; LONG TERM CARE; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; PRIORITY JOURNAL; REMISSION; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AORTA, ABDOMINAL; AORTA, THORACIC; AORTIC DISEASES; AORTOGRAPHY; ATHEROSCLEROSIS; CHOLESTEROL, LDL; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRROLES; TIME FACTORS; TREATMENT OUTCOME;

EID: 67449108189     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32832948a0     Document Type: Article

References (18)

1. Fayad ZA, Nahar T, Fallon JT, Goldman M, Aguinaldo JG, Badimon JJ, et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation 2000; 101: 2503–2509.
2. Taniguchi H, Momiyama Y, Fayad ZA, Ohmori R, Ashida K, Kihara T, et al. In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography. Am Heart J 2004; 148: 137–143.
3. Momiyama Y, Kato R, Fayad ZA, Tanaka N, Taniguchi H, Ohmori R, et al. A possible association between coronary plaque instability and complex plaques in abdominal aorta. Arterioscler Thromb Vasc Biol 2006; 26: 903–909.
4. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerotic in vivo. Circulation 1996; 94: 932–938.
5. Helft G, Worthley SG, Fuster V, Zaman AG, Schechter C, Osende JI, et al. Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. J Am Coll Cardiol 2001; 37: 1149–1154.
6. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years’ follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002; 106: 2884–2887.
7. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Chaplin WF, et al. Effects of aggressive versus conventional lipid lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 2005; 46: 106–112.
8. Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Higashi K, et al. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J Am Coll Cardiol 2005; 45: 733–742.
9. Ayaori M, Momiyama Y, Fayad ZA, Yonemura A, Ohmori R, Kihara T, et al. Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia. Atherosclerosis 2008; 196: 425–433.
10. Lima JAC, Desai MY, Steen H, Warren WP, Gautam S, Lai S. Statin-induced cholesterol lowering and plaque regression after 6 month of magnetic resonance imaging-monitored therapy. Circulation 2004; 110: 2336–2341.
11. Worthley SG, Helft G, Fuster V, Fayad ZA, Fallon JT, Osende JI, et al. High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. Atherosclerosis 2000; 150: 321–329.
12. Smilde TJ, van Wissen S, Wollersheim H, Trip MD, Kastelein JJ, Stalenhoef AF. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomized, double-blind trial. Lancet 2001; 357: 577–581.
13. Birgelen C, Hartmann M, Mintz GS, Baumgart D, Schmermund A, Erbel R. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (12 months) follow-up intravascular ultrasound. Circulation 2003; 108: 2757–2762.
14. Hong MK, Lee CW, Kim YH, Park DW, Lee SW, Park CB, et al. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy. Am J Cardiol 2006; 98: 866–870.
15. Overturf M, Sybers H, Schaper J, Taegtmeyer H. Hypertension and atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 1986; 59: 283–299.
16. Tribouilloy CM, Peltier M, Lannetta-Peltier MC, Zhu Z, Andrejak M, Lesbre JP. Relation between low-density lipoprotein cholesterol and thoracic aortic atherosclerosis. Am J Cardiol 1999; 84: 603–605.
17. Giral P, Pithois-Merli I, Filitti V, Levenson J, Plainfosse MC, Mainardi C, Simon A.C. Prevention Cardio-vasculaire en Medecine du Travail METRA Group. Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men. Arch Intern Med 1991; 151: 950–956.
18. Van Wissen S, Smilde TJ, de Groot E, Hutten BA, Kastelein JJ, Stalenhoef AF. The significance of femoral intima-media thickness and plaque scoring in the Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) Study. Eur J Cardiovasc Prev Rehabil 2003; 10: 451–455.